z-logo
Premium
CD 1d‐mediated activation of group 3 innate lymphoid cells drives IL ‐22 production
Author(s) -
Saez de Guinoa Julia,
Jimeno Rebeca,
Farhadi Nazanin,
Jervis Peter J,
Cox Liam R,
Besra Gurdyal S,
Barral Patricia
Publication year - 2017
Publication title -
embo reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.584
H-Index - 184
eISSN - 1469-3178
pISSN - 1469-221X
DOI - 10.15252/embr.201642412
Subject(s) - innate lymphoid cell , cd1d , biology , immune system , microbiology and biotechnology , innate immune system , immunology , antigen presentation , t cell , natural killer t cell
Innate lymphoid cells ( ILC s) are a heterogeneous family of immune cells that play a critical role in a variety of immune processes including host defence against infection, wound healing and tissue repair. Whether these cells are involved in lipid‐dependent immunity remains unexplored. Here we show that murine ILC s from a variety of tissues express the lipid‐presenting molecule CD 1d, with group 3 ILC s ( ILC 3s) showing the highest level of expression. Within the ILC 3 family, natural cytotoxicity triggering receptor ( NCR ) − CCR 6 + cells displayed the highest levels of CD 1d. Expression of CD 1d on ILC s is functionally relevant as ILC 3s can acquire lipids in vitro and in vivo and load lipids on CD 1d to mediate presentation to the T‐cell receptor of invariant natural killer T ( iNKT ) cells. Conversely, engagement of CD 1d in vitro and administration of lipid antigen in vivo induce ILC 3 activation and production of IL ‐22. Taken together, our data expose a previously unappreciated role for ILC s in CD 1d‐mediated immunity, which can modulate tissue homeostasis and inflammatory responses.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom